PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33481175-1	2021	PURPOSE: To assess in healthy volunteers the whole-body distribution and dosimetry of [11C]metoclopramide, a new positron emission tomography (PET) tracer to measure P-glycoprotein activity at the blood-brain barrier.	Metoclopramide	91-105	ATP binding cassette subfamily B member 1	Homo sapiens	166-180	
32200996-4	2020	Three radiolabeled substrates of the P-gp have been developed for clinical use: [11C]verapamil, [11C]-N-desmethyl-loperamide and [11C]metoclopramide.	Metoclopramide	134-148	ATP binding cassette subfamily B member 1	Homo sapiens	37-41	
31853677-1	2019	BACKGROUND: [11C]Metoclopramide is a new radiotracer for investigating the activity of P-glycoprotein at the blood-brain barrier.	Metoclopramide	12-31	ATP binding cassette subfamily B member 1	Homo sapiens	87-101	
29748235-2	2018	Many drugs, such as metoclopramide, are weak ABCB1 substrates and distribute into the brain even when ABCB1 is fully functional.	Metoclopramide	20-34	ATP binding cassette subfamily B member 1	Homo sapiens	45-50	
29748235-2	2018	Many drugs, such as metoclopramide, are weak ABCB1 substrates and distribute into the brain even when ABCB1 is fully functional.	Metoclopramide	20-34	ATP binding cassette subfamily B member 1	Homo sapiens	102-107	
26585058-0	2016	Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide.	Metoclopramide	83-97	ATP binding cassette subfamily B member 1	Homo sapiens	26-40	
26585058-0	2016	Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide.	Metoclopramide	83-97	ATP binding cassette subfamily B member 1	Homo sapiens	42-47